Franklin Resources
SIOX

Franklin Resources’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Franklin Resources’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55,570
Closed -$24.2K – 2418
2022
Q4 		$24.2K Hold
55,570
– – ﹤0.01% 2265
2022
Q3 		$16K Hold
55,570
– – ﹤0.01% 2269
2022
Q2 		$20K Sell
55,570
-26,552
-32% -$11K ﹤0.01% 2316
2022
Q1 		$55K Hold
82,122
– – ﹤0.01% 2361
2021
Q4 		$106K Sell
82,122
-378
-0.5% -$671 ﹤0.01% 2334
2021
Q3 		$179K Buy
+82,500
New +$179K ﹤0.01% 2256
2018
Q1 		– Sell
-128,179
Closed -$5.4M – 1558
2017
Q4 		$5.4M Sell
128,179
-42,275
-25% -$1.9M ﹤0.01% 1055
2017
Q3 		$9.38M Sell
170,454
-12,494
-7% -$2.11M ﹤0.01% 958
2017
Q2 		$33.9M Sell
182,948
-18,637
-9% -$3.27M 0.02% 647
2017
Q1 		$24.1M Hold
201,585
– – 0.01% 734
2016
Q4 		$20M Buy
201,585
+5,250
+3% +$553K 0.01% 791
2016
Q3 		$22M Buy
196,335
+37,500
+24% +$4.5M 0.01% 783
2016
Q2 		$16.3M Buy
158,835
+8,862
+6% +$886K 0.01% 859
2016
Q1 		$13.8M Buy
149,973
+951
+0.6% +$101K 0.01% 898
2015
Q4 		$21.5M Sell
149,022
-26,813
-15% -$3.49M 0.01% 817
2015
Q3 		$18.2M Sell
175,835
-39,419
-18% -$4.62M 0.01% 871
2015
Q2 		$35.1M Buy
+215,254
New +$36.5M 0.02% 730

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Franklin Resources's SIOX Position: Q1 2023 in Review

Franklin Resources sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 55,570 shares — an estimated $24.2K sold.

Franklin Resources first reported a position in SIOX in Q2 2015 and held it in 17 quarters. The position peaked at $35.1M in Q2 2015. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Franklin Resources reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Franklin Resources sold 55,570 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $24.2K.
  • Franklin Resources first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 17 quarters.
  • Franklin Resources's Sio Gene Therapies Inc. Common Stock position peaked at $35.1M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.